Radioiodine treatment for pediatric hyperthyroid Grave's disease.

Abstract

Grave's disease (GD) is an autoimmune disease in which excessive amounts of thyroid hormones circulate in the blood. Treatment for pediatric GD includes (1) antithyroid drugs (ATD), (2) radioiodine, and (3) thyroidectomy. Yet, the optimal therapy remains controversial. We collected studies from all electronically available sources as well as from conferences held in China. All studies using radioiodine and/or ATD and/or thyroidectomy were included. Information was found on 1,874 pediatric GD patients treated with radioiodine, 1,279 patients treated with ATD and 1,362 patients treated surgically. The cure rate for radioiodine was 49.8%; the incidence of hypothyroidism, 37.8%; of relapse, 6.3%; of adverse effects, 1.55%; and of drop outs, 0.6%. These data show that radioiodine treatment is safe and effective in pediatric GD with significant lower incidence of relapse and adverse effects but significantly higher incidence of hypothyroidism as compared with both ATD and thyroidectomy. For the time being, radioiodine treatment for pediatric GD remains an excellent first-line therapy and a good second-line therapy for patients with ATD failure, severe complications, or poor compliance.

• Authors: Ma Chao, Xie Jiawei, Wang Guoming, Liu Jianbin, Liu Wanxia, Al Driedger, Zuo Shuyao, Zhang Qin
• Journal: European journal of pediatrics (Eur J Pediatr) Vol. 168 Issue 10 Pg. 1165-9 (Oct 2009) ISSN: 1432-1076 [Electronic] Germany
• PMID: 19421775 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Antithyroid Agents
• Iodine Radioisotopes

Topics

• Antithyroid Agents (therapeutic use)
• Child
• Child, Preschool
• Graves Disease (drug therapy, radiotherapy)
• Humans
• Iodine Radioisotopes (therapeutic use)